Recon: AbbVie strikes pricing pact with the White House; FDA seeks removal of suicide warnings from weight-loss drugs
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States